Items where Author is "Parker, CC"

James, ND and Sydes, MR and Clarke, NW and Mason, MD and Dearnaley, DP and Spears, MR and Ritchie, AWS and Parker, CC and Russell, JM and Attard, G and De Bono, J and Cross, W and Jones, RJ and Thalmann, G and Amos, C and Matheson, D and Millman, R and Alzouebi, M and Beesley, S and Birtle, AJ and Brock, S and Cathomas, R and Chakraborti, P and Chowdhury, S and Cook, A and Elliott, T and Gale, J and Gibbs, S and Graham, JD and Hetherington, J and Hughes, R and Laing, R and McKinna, F and McLaren, DB and O'Sullivan, JM and Parikh, O and Peedell, C and Protheroe, A and Robinson, AJ and Srihari, N and Srinivasan, R and Staffurth, J and Sundar, S and Tolan, S and Tsang, D and Wagstaff, J and Parmar, MKB (2015) Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): Survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. The Lancet, 387 (10024). 1163 - 1177. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(15)01037-5

James, ND and Spears, MR and Clarke, NW and Dearnaley, DP and Mason, MD and Parker, CC and Ritchie, AWS and Russell, JM and Schiavone, F and Attard, G and others (2015) Failure-free survival and radiotherapy in patients with newly diagnosed nonmetastatic prostate cancer: data from patients in the control arm of the STAMPEDE trial. JAMA oncology. 1 - 10. DOI: https://doi.org/10.1001/jamaoncol.2015.4350

Attard, G and Sydes, MR and Mason, MD and Clarke, NW and Aebersold, D and de Bono, JS and Dearnaley, DP and Parker, CC and Ritchie, AWS and Russell, JM and Thalmann, G and Cassoly, E and Millman, R and Matheson, D and Schiavone, F and Spears, MR and Parmar, MKB and James, ND (2014) Combining Enzalutamide with Abiraterone, Prednisone, and Androgen Deprivation Therapy in the STAMPEDE Trial. European Urology. ISSN 0302-2838 DOI: https://doi.org/10.1016/j.eururo.2014.05.038